I
IRadimed Corporation
IRMD · NASDAQ · Healthcare · 1.1B
Closing price
$87.45
+1.83% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
49.5×
Price / net assetsP/B
11.8×
Enterprise value / EBITDAEV/EBITDA
34.5×
Free cash flow yieldFCF yield
1.5%
Return on equityROE
23.8%
Operating margin
31.2%
Net debt / EBITDAbalance-sheet strength
-1.7×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.